107 related articles for article (PubMed ID: 35606667)
1. Impact of baseline body mass index on the outcomes of patients with neuroendocrine neoplasms.
Abdel-Rahman O; Ghosh S; Morrish D
J Endocrinol Invest; 2022 Sep; 45(9):1683-1688. PubMed ID: 35606667
[TBL] [Abstract][Full Text] [Related]
2. Changes in Survival Outcomes of Patients With Neuroendocrine Neoplasms Over the Past 15 Years: A Real-World Study.
Abdel-Rahman O; Pham TM; Pokhrel A; Ruether D; Sawyer MB
Am J Clin Oncol; 2022 May; 45(5):208-214. PubMed ID: 35383575
[TBL] [Abstract][Full Text] [Related]
3. A Real-World, Population-Based Study for the Incidence and Outcomes of Neuroendocrine Neoplasms of Unknown Primary.
Abdel-Rahman O
Neuroendocrinology; 2021; 111(9):876-882. PubMed ID: 32980845
[TBL] [Abstract][Full Text] [Related]
4. Patterns of emergency department visits before diagnosis with digestive neuroendocrine neoplasms.
Abdel-Rahman O; Ghosh S
Int J Colorectal Dis; 2023 May; 38(1):148. PubMed ID: 37253995
[TBL] [Abstract][Full Text] [Related]
5. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population-based study.
Zhang P; Wang W; Lu M; Zeng C; Chen J; Li E; Tan H; Wang W; Yu X; Tang Q; Zhao J; Shen L; Li J
Cancer Med; 2018 Sep; 7(9):4361-4370. PubMed ID: 30062861
[TBL] [Abstract][Full Text] [Related]
7. Underweight, Markers of Cachexia, and Mortality in Acute Myocardial Infarction: A Prospective Cohort Study of Elderly Medicare Beneficiaries.
Bucholz EM; Krumholz HA; Krumholz HM
PLoS Med; 2016 Apr; 13(4):e1001998. PubMed ID: 27093615
[TBL] [Abstract][Full Text] [Related]
8. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
9. Impact of Body Mass Index on Outcomes of Autogenous Fistulas for Hemodialysis Access.
Arhuidese IJ; Holscher CM; Elemuo C; Parkerson GR; Johnson BL; Malas MB
Ann Vasc Surg; 2020 Oct; 68():192-200. PubMed ID: 32339695
[TBL] [Abstract][Full Text] [Related]
10. A Real-World, Population-Based Study for the Incidence and Outcomes of Neuroendocrine Neoplasms of Nondigestive, Nonpulmonary Primary.
Abdel-Rahman O; Ghosh S
Pancreas; 2022 Aug; 51(7):769-773. PubMed ID: 36395402
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of non-metastatic poorly differentiated gastroenteropancreatic neuroendocrine neoplasms treated with surgery: a real-world population-based study.
Abdel-Rahman O; Rahbari N; Reissfelder C; Oweira H
Int J Colorectal Dis; 2021 May; 36(5):941-947. PubMed ID: 33145607
[TBL] [Abstract][Full Text] [Related]
12. Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registry.
Bergstra SA; Allaart CF; Vega-Morales D; De Buck M; Murphy E; Salomon Escoto K; Huizinga TWJ
RMD Open; 2020 Jun; 6(2):. PubMed ID: 32506054
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients.
Ko SM; Lee J; Bae SJ; Baik SJ; Ji J; Kim D; Ahn SG; Jeong J
Br J Cancer; 2021 Jul; 125(1):119-125. PubMed ID: 33875823
[TBL] [Abstract][Full Text] [Related]
14. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
15. Survival Outcomes According to Body Mass Index in Hepatocellular Carcinoma Patient: Analysis of Nationwide Cancer Registry Database.
Cha B; Yu JH; Jin YJ; Suh YJ; Lee JW
Sci Rep; 2020 May; 10(1):8347. PubMed ID: 32433488
[TBL] [Abstract][Full Text] [Related]
16. Overweight is associated with improved survival and outcomes in patients with atrial fibrillation.
Wang J; Yang YM; Zhu J; Zhang H; Shao XH; Tian L; Huang B; Yu LT; Gao X; Wang M
Clin Res Cardiol; 2014 Jul; 103(7):533-42. PubMed ID: 24535378
[TBL] [Abstract][Full Text] [Related]
17. Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients.
Masel EK; Berghoff AS; Füreder LM; Heicappell P; Schlieter F; Widhalm G; Gatterbauer B; Dieckmann U; Birner P; Bartsch R; Schur S; Watzke HH; Zielinski CC; Preusser M
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28488812
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients.
Kim JY; Lee DW; Lee KH; Min A; Ryu HS; Lee HB; Moon HG; Kim TY; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA; Kim S
Breast Cancer Res Treat; 2019 Jul; 176(2):453-460. PubMed ID: 31028608
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations.
Panzuto F; Pusceddu S; Faggiano A; Rinzivillo M; Brighi N; Prinzi N; Riccardi F; Iannicelli E; Maggio I; Femia D; Tafuto S; Manuzzi L; Di Sarno A; Annibale B; de Braud F; Campana D;
Pancreatology; 2019 Dec; 19(8):1067-1073. PubMed ID: 31587962
[TBL] [Abstract][Full Text] [Related]
20. Impact of body mass index on survival of medical patients with sepsis: a prospective cohort study in a university hospital in China.
Zhou Q; Wang M; Li S; Zhang J; Ma Q; Ding Y; Ge H; Shen N; Zheng Y; Sun Y
BMJ Open; 2018 Sep; 8(9):e021979. PubMed ID: 30209156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
